FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NASDAQ:NSPH

Sort
E.g., 2013-05-23
E.g., 2013-05-23
Enter a comma separated list of user names.

Nanosphere, Inc (NASDAQ:NSPH) witnessed volume of 1.09 million shares during last trade however it holds an average trading capacity of 408,133 shares. NSPH last trade opened at $1.27 reached intraday low of $1.24 and went +5.60% up to close at $1.32.

Read Full Article and Disclaimer at :http://stockbling.com/7701/business-news/nanosphere-inc-non-normal-trade...

JAZZ, Jazz Pharmaceuticals, Inc.

** JAZZ and Azur Pharma Limited have agreed to combine to form Jazz Pharmaceuticals plc.

According to JAZZ, the combined company would have a diversified product portfolio, strong cash flow and expected annual revenues of more than $475 million.

Medicis Pharmaceutical Corp. (NYSE:MRX) is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions.

Nanosphere, Inc., (Nasdaq:NSPH), which develops, manufactures, and markets advanced molecular diagnostics systems, will report its results for the third quarter of 2010 after the market closes on Wednesday, November 3, 2010.

NSPH will also hold a live investor conference call and webcast at 5:00 P.M., Eastern Time.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Molecular Insight Pharmaceuticals, Inc. (NASDAQ:MIPI) presented positive data from Phase 1 clinical studies comparing Trofex™ (123I-MIP-1072), its lead molecular imaging candidate for the diagnosis and monitoring of metastatic prostate cancer, and ProstaScint® (111In-capromab pendetide), an imaging radiopharmaceutical for the visualization of metastatic prostate cancer.

ADVERTISE WITH US